ArchieMD wins NIH Phase I SBIR grant

InteliSpark client ArchieMD, Inc. has been awarded a $225,000 grant from the National Institute on Drug Abuse (NIDA). The award is a Phase I Small Business Innovation Research (SBIR) project entitled “An interactive app to promote safe and effective use of opioids in young children postoperatively.”

ArchieMD is a physician-led company that designs educational products for a variety of different audiences within health sciences. The company produces applications with different types of training programs and simulations and 3D simplified concepts with visual explanations making it easier for the audience to understand.  ArchieMD stands apart from its competitors because they evaluate the educational impact of their applications by using content guidance from nationally recognized subject matter experts along with partnering with leading healthcare institutions.

In recent years, there has been increased attention to pain in children and adolescents leading to a rise in the home use of opioid prescriptions. This has also lead to an increase in hospital visits (>21,000) and accidental overdose deaths in children and adolescence. The heart of this epidemic is directly related to parents having little to no training about opioid usage.

Under this SBIR project, ArchieMD will team up with the University of Michigan to develop a smartphone application. It will be designed for parents who have children prescribed to the home use of opioid prescriptions. The app will provide education and tools to help parents with accurate real-time assessments of both pain and analgesic related adverse drug events (AR-ADEs). The goal of the SBIR is to improve analgesic safety and efficiency by improving parent’s analgesic and pain management skills.